Connect with us

Hi, what are you looking for?

Tech & Science

Parexel and Sanofi collaborate on wearables study

The reason why the two companies are reviewing the application of wearables is because person-connected technology has the potential to improve data collection in relation to clinical trials. Moreover, the greater simplicity afforded by wearables may help to address problems with recruiting people to take part in clinical trials, such as recruitment, retention and patient engagement.

A further advantage stems from data collection and data analysis, for wearable devices have the ability to collect real-world data for investigational drugs, and for this information to be shared between scientists and with regulator like the U.S. Food and Drug Administration.

At present, the use of wearables remains a potential, which is why Sanofi and Parexel have come together – to see how effective and time-saving wearable technology is. There is a scarcity of supporting data at present.

Highlighting this, Xavier Flinois, who is President of Parexel Informatics, told the industry website PharmaPhorum: “We believe the use of wearables to collect data from trial participants represents a breakthrough in the digital transformation within the industry.”

The scientist-come-businessman added: “Working with Sanofi, we believe we have a strong opportunity to streamline and automate data collection from multiple devices, collect high-quality data remotely and generate meaningful results, all while reducing burden on patients and sites, as well as lowering costs.”

The potential of wearables will be assessed through a pilot study, focusing on Parexel’s Perceptive MyTrials, which is a clinical trial data-collection platform. The platform aims to produce data relating to investigational therapy and method effectiveness, bringing together data from wearables and sensors. One area to be looked at will probbaly be diabetes medications, an area that Sanofi specializes in.

Avatar photo
Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, business, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:


If this election turns into a random shooting war, things won’t end well for America.


As the bangs ran out, Trump clearly grimaced and clutched a hand to his right ear, on which blood could later be seen.


Swiss singer Nemo's 2024 Eurovision victory means Switzerland gets to host the glitzy TV extravaganza next year.


Catherine, Princess of Wales, will attend the Wimbledon Men's final in London on Sunday as she recovers after being diagnosed with cancer.